Login / Signup

Allergen immunotherapy: exploring areas for further inquiry.

Tam RamseyWanda LaiPeter F SviderHoumehr HojjatJean Anderson EloyAdam J Folbe
Published in: International forum of allergy & rhinology (2017)
Despite an immense interest in allergen immunotherapy, this analysis demonstrates that otolaryngologists represented a small proportion of PIs leading associated clinical trials and basic science inquiry. The proportion of trials with industry sponsorship has declined considerably in recent decades. These trends could help direct future resource allocation for allergen immunotherapy.
Keyphrases
  • clinical trial
  • allergic rhinitis
  • public health
  • current status
  • randomized controlled trial
  • phase ii
  • double blind